{"entity":{"type":"insider","cik":"0001279473","url":"/insider/0001279473","json_url":"/insider/0001279473.json","name":"INGENITO GARY","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":20,"n_filings":15,"first":"2019-11-22","last":"2025-05-15","span_basis":"filed_date"},"name_variants":[{"name":"INGENITO GARY","source":"filing","n_filings":15,"first_seen":"2019-11-22","last_seen":"2025-05-15"}],"transactions":[{"id":4905590,"accession":"0001161697-25-000175","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001161697-25-000175","line_url":"/filing/0001161697-25-000175#line-4","is_derivative":false,"issuer_cik":"0001279473","issuer_name":"CATALYST PHARMACEUTICALS, INC.","issuer_ticker":"CPRX","issuer_name_source":null,"issuer_url":"/issuer/0001279473","owner_cik":"0001279473","owner_name":"INGENITO GARY","owner_display_name":"INGENITO GARY","owner_url":"/insider/0001279473","role":"Officer (Chief Med. & Reg. Officer)","role_mark":"O","role_mark_label":"Officer (Chief Med. & Reg. Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Med. & Reg. Officer","security_title":"Common stock, par value $0.001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":44000.0,"shares_display":"44,000","price_per_share":23.63,"price_display":"23.63","price_state":"stated","total_value":1039720.0,"total_display":"1,039,720.00","total_whole":"1,039,720","shares_owned_after":68873.0,"shares_owned_after_display":"68,873","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-05-14","filed_date":"2025-05-15","scope":"insider"},{"id":4905583,"accession":"0001161697-25-000175","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001161697-25-000175","line_url":"/filing/0001161697-25-000175#line-2","is_derivative":false,"issuer_cik":"0001279473","issuer_name":"CATALYST PHARMACEUTICALS, INC.","issuer_ticker":"CPRX","issuer_name_source":null,"issuer_url":"/issuer/0001279473","owner_cik":"0001279473","owner_name":"INGENITO GARY","owner_display_name":"INGENITO GARY","owner_url":"/insider/0001279473","role":"Officer (Chief Med. & Reg. Officer)","role_mark":"O","role_mark_label":"Officer (Chief Med. & Reg. Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Med. & Reg. Officer","security_title":"Common stock, par value $0.001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200000.0,"shares_display":"200,000","price_per_share":23.68,"price_display":"23.68","price_state":"stated","total_value":4736000.0,"total_display":"4,736,000.00","total_whole":"4,736,000","shares_owned_after":68873.0,"shares_owned_after_display":"68,873","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-05-13","filed_date":"2025-05-15","scope":"insider"},{"id":4371730,"accession":"0001161697-25-000089","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001161697-25-000089","line_url":"/filing/0001161697-25-000089#line-4","is_derivative":false,"issuer_cik":"0001279473","issuer_name":"CATALYST PHARMACEUTICALS, INC.","issuer_ticker":"CPRX","issuer_name_source":null,"issuer_url":"/issuer/0001279473","owner_cik":"0001279473","owner_name":"INGENITO GARY","owner_display_name":"INGENITO GARY","owner_url":"/insider/0001279473","role":"Officer (Chief Med. & Reg. Officer)","role_mark":"O","role_mark_label":"Officer (Chief Med. & Reg. Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Med. & Reg. Officer","security_title":"Common stock, par value $0.001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":180096.0,"shares_display":"180,096","price_per_share":21.67,"price_display":"21.67","price_state":"stated","total_value":3902680.32,"total_display":"3,902,680.32","total_whole":"3,902,680","shares_owned_after":68873.0,"shares_owned_after_display":"68,873","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-06","filed_date":"2025-03-07","scope":"insider"},{"id":4371723,"accession":"0001161697-25-000089","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001161697-25-000089","line_url":"/filing/0001161697-25-000089#line-2","is_derivative":false,"issuer_cik":"0001279473","issuer_name":"CATALYST PHARMACEUTICALS, INC.","issuer_ticker":"CPRX","issuer_name_source":null,"issuer_url":"/issuer/0001279473","owner_cik":"0001279473","owner_name":"INGENITO GARY","owner_display_name":"INGENITO GARY","owner_url":"/insider/0001279473","role":"Officer (Chief Med. & Reg. Officer)","role_mark":"O","role_mark_label":"Officer (Chief Med. & Reg. Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Med. & Reg. Officer","security_title":"Common stock, par value $0.001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":44904.0,"shares_display":"44,904","price_per_share":22.09,"price_display":"22.09","price_state":"stated","total_value":991929.36,"total_display":"991,929.36","total_whole":"991,929","shares_owned_after":68873.0,"shares_owned_after_display":"68,873","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-05","filed_date":"2025-03-07","scope":"insider"},{"id":2980824,"accession":"0001161697-24-000492","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001161697-24-000492","line_url":"/filing/0001161697-24-000492","is_derivative":false,"issuer_cik":"0001279473","issuer_name":"CATALYST PHARMACEUTICALS, INC.","issuer_ticker":"CPRX","issuer_name_source":null,"issuer_url":"/issuer/0001279473","owner_cik":"0001279473","owner_name":"INGENITO GARY","owner_display_name":"INGENITO GARY","owner_url":"/insider/0001279473","role":"Officer (Chief Med. & Reg. Officer)","role_mark":"O","role_mark_label":"Officer (Chief Med. & Reg. Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Med. & Reg. Officer","security_title":"Common stock, par value $0.001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12000.0,"shares_display":"12,000","price_per_share":22.72118975,"price_display":"22.72","price_state":"stated","total_value":272654.277,"total_display":"272,654.28","total_whole":"272,654","shares_owned_after":54760.0,"shares_owned_after_display":"54,760","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-27","filed_date":"2024-11-29","scope":"insider","n_lines":2},{"id":2792584,"accession":"0001161697-24-000458","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001161697-24-000458","line_url":"/filing/0001161697-24-000458#line-2","is_derivative":false,"issuer_cik":"0001279473","issuer_name":"CATALYST PHARMACEUTICALS, INC.","issuer_ticker":"CPRX","issuer_name_source":null,"issuer_url":"/issuer/0001279473","owner_cik":"0001279473","owner_name":"INGENITO GARY","owner_display_name":"INGENITO GARY","owner_url":"/insider/0001279473","role":"Officer (Chief Med. & Reg. Officer)","role_mark":"O","role_mark_label":"Officer (Chief Med. & Reg. Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Med. & Reg. Officer","security_title":"Common stock, par value $0.001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":38000.0,"shares_display":"38,000","price_per_share":21.199,"price_display":"21.20","price_state":"stated","total_value":805562.0,"total_display":"805,562.00","total_whole":"805,562","shares_owned_after":51391.0,"shares_owned_after_display":"51,391","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-20","filed_date":"2024-11-22","scope":"insider"},{"id":2178095,"accession":"0001161697-24-000340","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001161697-24-000340","line_url":"/filing/0001161697-24-000340#line-2","is_derivative":false,"issuer_cik":"0001279473","issuer_name":"CATALYST PHARMACEUTICALS, INC.","issuer_ticker":"CPRX","issuer_name_source":null,"issuer_url":"/issuer/0001279473","owner_cik":"0001279473","owner_name":"INGENITO GARY","owner_display_name":"INGENITO GARY","owner_url":"/insider/0001279473","role":"Officer (Chief Med. & Reg. Officer)","role_mark":"O","role_mark_label":"Officer (Chief Med. & Reg. Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Med. & Reg. Officer","security_title":"Common stock, par value $0.001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100000.0,"shares_display":"100,000","price_per_share":18.04,"price_display":"18.04","price_state":"stated","total_value":1804000.0,"total_display":"1,804,000.00","total_whole":"1,804,000","shares_owned_after":51391.0,"shares_owned_after_display":"51,391","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-08-09","filed_date":"2024-08-13","scope":"insider"},{"id":2088814,"accession":"0001161697-24-000256","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001161697-24-000256","line_url":"/filing/0001161697-24-000256#line-2","is_derivative":false,"issuer_cik":"0001279473","issuer_name":"CATALYST PHARMACEUTICALS, INC.","issuer_ticker":"CPRX","issuer_name_source":null,"issuer_url":"/issuer/0001279473","owner_cik":"0001279473","owner_name":"INGENITO GARY","owner_display_name":"INGENITO GARY","owner_url":"/insider/0001279473","role":"Officer (Chief Med. & Reg. Officer)","role_mark":"O","role_mark_label":"Officer (Chief Med. & Reg. Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Med. & Reg. Officer","security_title":"Common stock, par value $0.001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":80000.0,"shares_display":"80,000","price_per_share":16.16,"price_display":"16.16","price_state":"stated","total_value":1292800.0,"total_display":"1,292,800.00","total_whole":"1,292,800","shares_owned_after":51391.0,"shares_owned_after_display":"51,391","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-06-05","filed_date":"2024-06-07","scope":"insider"},{"id":8721800,"accession":"0001161697-23-000588","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001161697-23-000588","line_url":"/filing/0001161697-23-000588#line-2","is_derivative":false,"issuer_cik":"0001279473","issuer_name":"CATALYST PHARMACEUTICALS, INC.","issuer_ticker":"CPRX","issuer_name_source":null,"issuer_url":"/issuer/0001279473","owner_cik":"0001279473","owner_name":"INGENITO GARY","owner_display_name":"INGENITO GARY","owner_url":"/insider/0001279473","role":"Officer (Chief Med. & Reg. Officer)","role_mark":"O","role_mark_label":"Officer (Chief Med. & Reg. Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Med. & Reg. Officer","security_title":"Common stock, par value $0.001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50000.0,"shares_display":"50,000","price_per_share":14.02,"price_display":"14.02","price_state":"stated","total_value":701000.0,"total_display":"701,000.00","total_whole":"701,000","shares_owned_after":38367.0,"shares_owned_after_display":"38,367","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-06","filed_date":"2023-12-08","scope":"insider"},{"id":6692238,"accession":"0001161697-22-000574","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001161697-22-000574","line_url":"/filing/0001161697-22-000574#line-2","is_derivative":false,"issuer_cik":"0001279473","issuer_name":"CATALYST PHARMACEUTICALS, INC.","issuer_ticker":"CPRX","issuer_name_source":null,"issuer_url":"/issuer/0001279473","owner_cik":"0001279473","owner_name":"INGENITO GARY","owner_display_name":"INGENITO GARY","owner_url":"/insider/0001279473","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common stock, par value $0.001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5918.0,"shares_display":"5,918","price_per_share":16.85,"price_display":"16.85","price_state":"stated","total_value":99718.3,"total_display":"99,718.30","total_whole":"99,718","shares_owned_after":30802.0,"shares_owned_after_display":"30,802","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-06","filed_date":"2022-12-08","scope":"insider"},{"id":6406963,"accession":"0001161697-22-000468","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001161697-22-000468","line_url":"/filing/0001161697-22-000468","is_derivative":false,"issuer_cik":"0001279473","issuer_name":"CATALYST PHARMACEUTICALS, INC.","issuer_ticker":"CPRX","issuer_name_source":null,"issuer_url":"/issuer/0001279473","owner_cik":"0001279473","owner_name":"INGENITO GARY","owner_display_name":"INGENITO GARY","owner_url":"/insider/0001279473","role":"Officer (Chief Medical & Reg. Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical & Reg. Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical & Reg. Officer","security_title":"Common stock, par value $0.001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":143000.0,"shares_display":"143,000","price_per_share":15.67453846153846,"price_display":"15.67","price_state":"stated","total_value":2241459.0,"total_display":"2,241,459.00","total_whole":"2,241,459","shares_owned_after":22053.0,"shares_owned_after_display":"22,053","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-09-14","filed_date":"2022-09-16","scope":"insider","n_lines":2},{"id":6650578,"accession":"0001161697-22-000319","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001161697-22-000319","line_url":"/filing/0001161697-22-000319#line-4","is_derivative":false,"issuer_cik":"0001279473","issuer_name":"CATALYST PHARMACEUTICALS, INC.","issuer_ticker":"CPRX","issuer_name_source":null,"issuer_url":"/issuer/0001279473","owner_cik":"0001279473","owner_name":"INGENITO GARY","owner_display_name":"INGENITO GARY","owner_url":"/insider/0001279473","role":"Officer (Chief Medical & Reg. Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical & Reg. Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical & Reg. Officer","security_title":"Common stock, par value $0.001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6152.0,"shares_display":"6,152","price_per_share":6.607,"price_display":"6.61","price_state":"stated","total_value":40646.264,"total_display":"40,646.26","total_whole":"40,646","shares_owned_after":22053.0,"shares_owned_after_display":"22,053","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-06-22","filed_date":"2022-06-23","scope":"insider"},{"id":6650575,"accession":"0001161697-22-000319","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001161697-22-000319","line_url":"/filing/0001161697-22-000319#line-2","is_derivative":false,"issuer_cik":"0001279473","issuer_name":"CATALYST PHARMACEUTICALS, INC.","issuer_ticker":"CPRX","issuer_name_source":null,"issuer_url":"/issuer/0001279473","owner_cik":"0001279473","owner_name":"INGENITO GARY","owner_display_name":"INGENITO GARY","owner_url":"/insider/0001279473","role":"Officer (Chief Medical & Reg. Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical & Reg. Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical & Reg. Officer","security_title":"Common stock, par value $0.001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":143848.0,"shares_display":"143,848","price_per_share":6.595,"price_display":"6.60","price_state":"stated","total_value":948677.56,"total_display":"948,677.56","total_whole":"948,678","shares_owned_after":22053.0,"shares_owned_after_display":"22,053","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-06-21","filed_date":"2022-06-23","scope":"insider"},{"id":5451289,"accession":"0001161697-21-000569","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001161697-21-000569","line_url":"/filing/0001161697-21-000569#line-2","is_derivative":false,"issuer_cik":"0001279473","issuer_name":"CATALYST PHARMACEUTICALS, INC.","issuer_ticker":"CPRX","issuer_name_source":null,"issuer_url":"/issuer/0001279473","owner_cik":"0001279473","owner_name":"INGENITO GARY","owner_display_name":"INGENITO GARY","owner_url":"/insider/0001279473","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common stock, par value $0.001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3612.0,"shares_display":"3,612","price_per_share":6.987,"price_display":"6.99","price_state":"stated","total_value":25237.044,"total_display":"25,237.04","total_whole":"25,237","shares_owned_after":22053.0,"shares_owned_after_display":"22,053","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-07","filed_date":"2021-12-08","scope":"insider"},{"id":3291871,"accession":"0001161697-20-000604","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001161697-20-000604","line_url":"/filing/0001161697-20-000604#line-2","is_derivative":false,"issuer_cik":"0001279473","issuer_name":"CATALYST PHARMACEUTICALS, INC.","issuer_ticker":"CPRX","issuer_name_source":null,"issuer_url":"/issuer/0001279473","owner_cik":"0001279473","owner_name":"INGENITO GARY","owner_display_name":"INGENITO GARY","owner_url":"/insider/0001279473","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common stock, par value $0.001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3668.0,"shares_display":"3,668","price_per_share":3.447,"price_display":"3.45","price_state":"stated","total_value":12643.596,"total_display":"12,643.60","total_whole":"12,644","shares_owned_after":10998.0,"shares_owned_after_display":"10,998","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-22","filed_date":"2020-12-28","scope":"insider"},{"id":8096820,"accession":"0001161697-19-000538","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001161697-19-000538","line_url":"/filing/0001161697-19-000538#line-2","is_derivative":false,"issuer_cik":"0001279473","issuer_name":"CATALYST PHARMACEUTICALS, INC.","issuer_ticker":"CPRX","issuer_name_source":null,"issuer_url":"/issuer/0001279473","owner_cik":"0001279473","owner_name":"INGENITO GARY","owner_display_name":"INGENITO GARY","owner_url":"/insider/0001279473","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common stock, par value $0.001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":150000.0,"shares_display":"150,000","price_per_share":4.821,"price_display":"4.82","price_state":"stated","total_value":723150.0,"total_display":"723,150.00","total_whole":"723,150","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-12-05","filed_date":"2019-12-06","scope":"insider"},{"id":8157158,"accession":"0001161697-19-000508","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001161697-19-000508","line_url":"/filing/0001161697-19-000508#line-2","is_derivative":false,"issuer_cik":"0001279473","issuer_name":"CATALYST PHARMACEUTICALS, INC.","issuer_ticker":"CPRX","issuer_name_source":null,"issuer_url":"/issuer/0001279473","owner_cik":"0001279473","owner_name":"INGENITO GARY","owner_display_name":"INGENITO GARY","owner_url":"/insider/0001279473","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common stock, par value $0.001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100000.0,"shares_display":"100,000","price_per_share":4.66,"price_display":"4.66","price_state":"stated","total_value":466000.0,"total_display":"466,000.00","total_whole":"466,000","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-11-27","filed_date":"2019-11-27","scope":"insider"},{"id":8737370,"accession":"0001161697-19-000503","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001161697-19-000503","line_url":"/filing/0001161697-19-000503#line-2","is_derivative":false,"issuer_cik":"0001279473","issuer_name":"CATALYST PHARMACEUTICALS, INC.","issuer_ticker":"CPRX","issuer_name_source":null,"issuer_url":"/issuer/0001279473","owner_cik":"0001279473","owner_name":"INGENITO GARY","owner_display_name":"INGENITO GARY","owner_url":"/insider/0001279473","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common stock, par value $0.001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100000.0,"shares_display":"100,000","price_per_share":4.498,"price_display":"4.50","price_state":"stated","total_value":449800.0,"total_display":"449,800.00","total_whole":"449,800","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-11-21","filed_date":"2019-11-22","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":20,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":20,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":20},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001369568","name":"CATALYST PHARMACEUTICALS, INC.","url":"/issuer/0001369568","role":"Officer (Chief Med. & Reg. Officer)","n_filings":15,"first_seen":"2019-11-22","last_seen":"2025-05-15"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001279473","retrieved_at":"2026-08-24T19:14:22+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}